LOGIQ E9
Device
GE HEALTHCARE
Total Payments
$91,733
Transactions
3
Doctors
0
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2021 | $59,839 | 1 | 0 |
| 2017 | $31,894 | 2 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $91,733 | 3 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| PLATELET-RICH PLASMA THERAPY FOR PATELLAR TENDINOPATHY: A RANDOMIZED CONTROLLED TRIAL CORRELATING CLINICAL BIOMECHANICAL AND NOVEL IMAGING BIOMARKERS | GE Healthcare | $59,839 | 0 |
| ULTRASOUND SYSTEM PERFORMANCE EVALUATION | GE HEALTHCARE | $16,894 | 0 |
| EVALUATION OF CLINICAL BENEFITS OF BFLOW WITH THE LOGIQ E9 ULTRASOUND SYSTEM | GE HEALTHCARE | $15,000 | 0 |
Top Doctors Receiving Payments for LOGIQ E9
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Seattle, WA | $91,733 | 3 |
Ad
Manufacturing Companies
- GE Healthcare $59,839
- GE HEALTHCARE $31,894
Product Information
- Type Device
- Total Payments $91,733
- Total Doctors 0
- Transactions 3
About LOGIQ E9
LOGIQ E9 is a device associated with $91,733 in payments to 0 healthcare providers, recorded across 3 transactions in the CMS Open Payments database. The primary manufacturer is GE HEALTHCARE.
Payment data is available from 2017 to 2021. In 2021, $59,839 was paid across 1 transactions to 0 doctors.
The most common payment nature for LOGIQ E9 is "Unspecified" ($91,733, 100.0% of total).
LOGIQ E9 is associated with 3 research studies, including "PLATELET-RICH PLASMA THERAPY FOR PATELLAR TENDINOPATHY: A RANDOMIZED CONTROLLED TRIAL CORRELATING CLINICAL BIOMECHANICAL AND NOVEL IMAGING BIOMARKERS" ($59,839).